Gene · 996
CDC27: cell division cycle 27
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CDC27: cell division cycle 27. Genes, record 996. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/996
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P30260 | Cell division cycle protein 27 homolog | 824 | 25 | Ensembl, GeneID, HGNC |
Source UniProt
Patents27
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40776 | P30260 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 95 | P30260 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 95 | P30260 | Espacenet |
| EP 4487869 A2 | 2025-01-08 | 89 | P30260 | Espacenet |
| KR 1020240027895 A | 2024-03-04 | 281 | P30260 | Espacenet |
| JP 2023036863 A | 2023-03-14 | 281 | P30260 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13714 | P30260 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 116685 | P30260 | Espacenet |
| US 10918740 B2 | 2021-02-16 | 979 | P30260 | Espacenet |
| US 10869935 B2 | 2020-12-22 | 979 | P30260 | Espacenet |
1 to 10 of 27
See all 27 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,261
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CDC27 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 10 | 2025 |
| R35GM128855 | Spindle Assembly Checkpoint Silencing | 9 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 8 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 7 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 4 | 2025 |
1 to 10 of 1,261Source NIH's project files
See all 1,261 nih grantsPapers1,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Molecular Profiling of Endometrial Cancer: NGS Findings, MSI/MMR Status, Histopathological Features, and TCGA-Inspired Molecular Classification. | Biomedicines | 2026 | 42792624 | PubTator, text mining | PubMed |
| Mutation Severity of FBXO43 Determines Spermatogenic Outcome and Informs Precision ART Strategies. | Hum Mutat | 2026 | 42597893 | PubTator, text mining | PubMed |
| Co-overexpression of CDC27 and PD-L1 defines an ultra-high-risk subgroup of acute myeloid leukemia in an Egyptian cohort. | J Immunoassay Immunochem | 2026 | 42538830 | PubTator, text mining | PubMed |
| Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer. | Cancers (Basel) | 2026 | 42279425 | PubTator, text mining | PubMed |
| Metabolomic profiling delineates the role of adenosine in oocyte quality and embryonic development. | Cell Death Dis | 2026 | 42265076 | PubTator, text mining | PubMed |
| Whole exome sequencing of lung cancer in Indian patients reveals driver genes and novel mutations with therapeutic potential. | Indian J Surg Oncol | 2026 | 42038570 | PubTator, text mining | PubMed |
| Functional status and health-related quality of life following Young and Burgess classified pelvic ring injuries. | PLoS One | 2026 | 41955237 | PubTator, text mining | PubMed |
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| ZBTB7A promotes malignant phenotypes in ovarian cancer through transcriptional activation of CRLF1. | Oncol Rep | 2026 | 41891980 | PubTator, text mining | PubMed |
| Uev1A counteracts oncogenic Ras stimuli in both polyploid and diploid cells. | Elife | 2026 | 41879050 | PubTator, text mining | PubMed |
1 to 10 of 1,552
See all 1,552 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/996
GET https://conductscience.org/api/genes/v1/996/patents?page=2